Target intelligence / Profile preview

FLRT2 antisense RNA 1 (FLRT2-AS1)

Target
FLRT2-AS1
Molecular classification
Antisense long non-coding RNA (lncRNA), Other (regulatory RNA, non-coding RNA)
01

Overview

FLRT2 antisense RNA 1 (FLRT2-AS1) is a non-coding antisense RNA transcribed from the promoter region of the FLRT2 gene. This lncRNA is part of a broader class of regulatory RNAs that may influence gene expression through RNA-RNA interactions or chromatin modification, though its specific biological function remains to be characterized in experimental studies. FLRT2-AS1 is one of several non-coding RNAs transcribed in the FLRT2 locus, and may play a regulatory role via interaction with the sense FLRT2 transcript, as found in other antisense lncRNA/gene pairs. Explicit biological functions of FLRT2-AS1 have not been established in scientific literature as of the current knowledge search. There is insufficient evidence currently linking FLRT2-AS1 directly to any disease; its sense gene, FLRT2, is implicated in cell migration, adhesion, neurodevelopment, and possibly cancer, but a direct disease association for the antisense RNA has not been established. No direct link to disease or therapeutic strategies has been described to date. FLRT2-AS1 is a non-coding RNA, not a protein target. It is not currently a known therapeutic target or biomarker, and no drugs, mechanisms of action, or safety concerns have been reported.

Other names
AL049775.1FLRT2-AS1
02

Biological functions

Putative regulation of FLRT2 gene expression (by typical lncRNA antisense mechanisms, such as RNA-RNA interaction or chromatin remodeling)General: Possible involvement in epigenetic and transcriptional regulation, by analogy to other antisense lncRNAs
03

Disease associations

Other

Beyond the preview

Go deeper on FLRT2 antisense RNA 1 (FLRT2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FLRT2 antisense RNA 1 (FLRT2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call